Back
Rhythm Pharmaceuticals Vs. DocuSign Industry Stock Comparison
Sell
46
RYTM
Rhythm Pharmaceuticals
Last Price:
$56.49
Seasonality Move:
-14.94%
Buy
79
DOCU
DocuSign
Last Price:
$95.73
Seasonality Move:
0.36%
Sell
46
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $55.85. The Score for RYTM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $55.85The current trend is relatively stagnant and RYTM is experiencing slight buying pressure.
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 46.14 | Sell |
Chaikin Money Flow: | 10036 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.82 - 60.58) | Sell |
Bollinger Bands (100): | (46.59 - 58.07) | Buy |
DOCU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.3 | Buy |
Relative Strength Index (14 RSI): | 58.86 | Buy |
Chaikin Money Flow: | -901725 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (81.39 - 97.61) | Buy |
Bollinger Bands (100): | (55.72 - 84.04) | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.56 | Buy |
20-day SMA: | 57.84 | Sell |
50-day SMA: | 56.36 | Sell |
200-day SMA: | 47.04 | Buy |
8-day EMA: | 55.99 | Sell |
20-day EMA: | 56.89 | Sell |
50-day EMA: | 56 | Sell |
200-day EMA: | 48.31 | Buy |
DOCU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 95.3 | Sell |
20-day SMA: | 91.52 | Buy |
50-day SMA: | 81.6 | Buy |
200-day SMA: | 63.13 | Buy |
8-day EMA: | 94.8 | Buy |
20-day EMA: | 91.58 | Buy |
50-day EMA: | 83.08 | Buy |
200-day EMA: | 66.81 | Buy |
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.77 per share.
DocuSign Earnings Growth & DOCU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.96 per share, and an increase next year of $0.66 per share.
Rhythm Pharmaceuticals Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
DocuSign Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |